Cargando…
VISTA: A Target to Manage the Innate Cytokine Storm
In recent years, the success of immunotherapy targeting immunoregulatory receptors (immune checkpoints) in cancer have generated enthusiastic support to target these receptors in a wide range of other immune related diseases. While the overwhelming focus has been on blockade of these inhibitory path...
Autores principales: | ElTanbouly, Mohamed A., Zhao, Yanding, Schaafsma, Evelien, Burns, Christopher M., Mabaera, Rodwell, Cheng, Chao, Noelle, Randolph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905033/ https://www.ncbi.nlm.nih.gov/pubmed/33643285 http://dx.doi.org/10.3389/fimmu.2020.595950 |
Ejemplares similares
-
VISTA Re-programs Macrophage Biology Through the Combined Regulation of Tolerance and Anti-inflammatory Pathways
por: ElTanbouly, Mohamed A., et al.
Publicado: (2020) -
Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
por: Broughton, Thomas W. K., et al.
Publicado: (2019) -
Influence of T Cell-Mediated Immune Surveillance on Somatic Mutation Occurrences in Melanoma
por: Jiang, Chongming, et al.
Publicado: (2022) -
VISTA expression and patient selection for immune-based anticancer therapy
por: Martin, Alexander S., et al.
Publicado: (2023) -
Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice
por: Sergent, PA, et al.
Publicado: (2017)